Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors [NA]
This clinical trial compares an exercise program to a health education program to see if either approach reduces fatigue and pain in breast …
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer [NA]
This clinical trial update notes a study assessing whether omega-3 fatty acids can prevent breast cancer in women at high risk; sponsor is C…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation [Phase 1]
Phase 1 clinical trial update investigating Interleukin-12 as treatment for women with metastatic breast cancer who have undergone high-dose…
-
FDA approval · 2013-09-16FDA Approved: CAPECITABINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Capecitabine as an original application for Teva Pharmaceuticals USA, confirming a generic version of the chemotherapy agent.
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer [Phase 1]
Update on a Phase 1 trial of cyclosporine A in combination with nab-paclitaxel for metastatic breast cancer; the study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-09-16Clinical Trial Update: Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas
This clinical trial update examines the prognostic value of the P63 marker in adenocarcinomas of the lung, breast, and pancreas, with the cu…
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma. [Phase 1, Phase 2]
Pfizer's MEK inhibitor PD-325901 was tested in Phase 1/2 trials for advanced breast cancer, colorectal cancer, and melanoma, but the study w…
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: Comparison Study of Breast Computed Tomography (CT) With Magnetic Resonance Imaging (MRI)
A completed clinical trial comparing breast computed tomography (CT) with magnetic resonance imaging (MRI) in patients with breast cancer.
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer [Phase 3]
The BEATRICE Phase 3 trial evaluating bevacizumab as adjuvant therapy in triple-negative breast cancer has completed, and results have been …
-
CLINICAL_TRIALS research · 2013-09-10Clinical Trial Update: Study to Evaluate Markers of Response in Locally Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating markers of response in locally advanced breast cancer; current status shows the study is completed.
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Ultrasound and Mammography for Screening Breast Cancer in Chinese Women [NA]
Completed clinical trial evaluating ultrasound and mammography as screening tools for breast cancer in Chinese women.
-
CLINICAL_TRIALS trial_result · 2013-09-06Clinical Trial Update: Regenerative Tissue Matrix for Breast Reconstruction [NA]
A completed clinical trial evaluating Regenerative Tissue Matrix for breast reconstruction in breast cancer patients.
-
CLINICAL_TRIALS research · 2013-09-05Clinical Trial Update: Protocol for Women at Increased Risk of Developing Breast Cancer [Phase 2]
This document updates a Phase 2 clinical trial protocol for women at increased risk of developing breast cancer; results were posted in 2013…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery [Phase 2]
Phase 2 trial evaluating doxorubicin and cyclophosphamide in older women with surgically removed Stage I-III breast cancer; the study has co…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer [Phase 2]
A Phase 2 study assessing radiation therapy as part of breast cancer treatment in older women undergoing surgery for stage I/II breast cance…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Docetaxel in Treating Older Women With Metastatic Breast Cancer [Phase 2]
This is a Phase 2 clinical trial update on docetaxel for older women with metastatic breast cancer. The study has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Impact of OncoDoc2 on Guideline Compliance in the Management of Breast Cancer [NA]
A completed clinical trial evaluating the impact of the decision-support tool OncoDoc2 on guideline compliance in the management of breast c…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Early Cardiac Toxicity of Adjuvant CT in Elderly BC. [Phase 2]
Phase 2 trial in elderly breast cancer patients investigating adjuvant chemotherapy reports early cardiac toxicity and the study was termina…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients [Phase 2]
Late cardiac safety evaluation results from a three-arm Belgian Phase 2 trial in node-positive early breast cancer are reported.
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer [Phase 1]
An update on a Phase Ib study of selatinib ditosilate tablets in patients with advanced breast cancer. The current status of the trial is no…
-
FDA approval · 2013-08-29FDA Approved: KADCYLA — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for KADCYLA (ado-trastuzumab emtansine) submitted by Genentech, resulting in an updated label/in…
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer [Phase 3]
Phase 3 trial evaluating whether calcium and magnesium can prevent ixabepilone-induced peripheral neuropathy in breast cancer patients was t…
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: RayGel-An Alternative for Skin Care During External Beam Radiation [Phase 2]
A Phase 2 clinical trial evaluating RayGel-An as a skin care agent during external beam radiation for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial from Dartmouth-Hitchcock Medical Center evaluated combining chemotherapy with filgrastim in patients with advanced solid tum…
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer [NA]
Completed clinical trial comparing Blue Citrus to placebo in postmenopausal women with estrogen receptor-positive breast cancer receiving ar…